Efficacy and Safety of Refeeding in Preterm Infants With Enterostomy
NCT02812095 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2021-03-18
Summary
Refeeding is an extracorporeal stool transport from the proximal stoma end to the distal end of stoma. Refeeding may be beneficial in preventing malabsorption, electrolyte imbalance, cholestasis and atrophy of the distal intestine. Investigators are focused on evaluating the efficacy and safety of the practice of refeeding in preterm infants with enterostomy. Clinical data including weight gain, total parenteral nutrition (TPN) usage, and other laboratory findings will be collected. Serial citrulline levels during refeeding procedure and pathologic specimens of bowel (at the time of stoma closure) will be collected for evaluating bowel adaptation.
Conditions
- Enterostomy
Interventions
- PROCEDURE
-
Refeeding
when amount of feeding reach to 120mL/kg a day,
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Max Age
- 35 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-08-31
- Primary Completion
- 2019-12-11
- Completion
- 2020-04-16
Countries
- South Korea
Study Locations
More Related Trials
-
Seasonal Variations and Different Treatment Protocols of Intussusception in Children: Our Centers Experiences
NCT04454320 ·Status: UNKNOWN
-
Effects of Parenteral L-carnitine Supplementation in Premature Neonates
NCT00841295 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Action for the Enterra Medical Gastric Electrical Stimulator
NCT06582576 ·Status: RECRUITING
-
Nutritional Management of Neurologically Impaired Children Across China
NCT06612736 ·Status: COMPLETED
-
Effects of Recto-colic Enemas of Butyrate on the Digestive Disorders of Very Low Birth Weight Preterms <1250 Grams
NCT01536483 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders
NCT01137240 ·Status: COMPLETED
-
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
NCT01576003 ·Status: COMPLETED ·Phase: NA
-
Three Dietary Regimens in Pre-colonoscopic Bowel Preparation in Children
NCT05609591 ·Status: COMPLETED ·Phase: NA
-
Impact of Visceral Osteopathic Treatment on Meconium Evacuation in Preterm Infants
NCT02140710 ·Status: COMPLETED ·Phase: PHASE4
-
Environmental Enteropathy Among Infants and Children With Growth Faltering
NCT06497907 ·Status: COMPLETED ·Phase: NA
-
Use of Prokinetics in Early Enteral Feeding in Preterm Infants
NCT01569633 ·Status: WITHDRAWN ·Phase: NA
-
Mechanisms and Management of Infant Dysphagia
NCT02583360 ·Status: COMPLETED ·Phase: NA
-
Multi-Center Study of Different Doses Domperidone in Feeding Intolerance
NCT02980250 ·Status: COMPLETED ·Phase: PHASE4
-
Magnetic Resonance Imaging in Paediatric Constipation
NCT03564249 ·Status: COMPLETED ·Phase: NA
-
A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
NCT05635747 ·Status: ENROLLING_BY_INVITATION
-
Pectin Use in Pediatric Intestinal Rehabilitation
NCT04224168 ·Status: UNKNOWN ·Phase: NA
-
Electrogastrography (EGC) in Premature Infants With Feeding Intolerance
NCT00008736 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children
NCT06514079 ·Status: RECRUITING ·Phase: NA
-
Oral Exploration of Objects and Food Diversification
NCT05157633 ·Status: COMPLETED
-
Effect of Protein Composition on Gastric Emptying
NCT00345566 ·Status: UNKNOWN ·Phase: NA
-
Intestinal Function in Neonates With Complex Congenital Heart Disease
NCT01475357 ·Status: COMPLETED ·Phase: NA
-
Effects of Fat-soluble Vitamins Supplementation on Common Complications and Neural Development in Very Low Birth Weight Infants
NCT03876704 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Dexmedetomidine of Gastrointestinal Motility
NCT04798482 ·Status: COMPLETED ·Phase: PHASE4
-
Lanreotide in the Treatment of Small Bowel Motility Disorders
NCT03012594 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Consequences of Necrotizing Enterocolitis in the Newborn Period
NCT03091907 ·Status: COMPLETED